ciprofloxacin hydrochloride monohydrate Tablets, film coated 250 mg, 500 mg, 750 mg
Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #688
A pharmaceutical manufacturer based in the EU that is active in 60+ countries selling its products in Europe, Africa, Middle East, and Asia for 50+ years.
Main therapeutic areas include cardiovascular, anti-infectives, and skin disorders.
The main dosage forms are semi-solid and liquid forms. They are produced in GMP-compliant manufacture.
Regularity team prepares EU CTD format document.
Manufacturer usually replies in 32 days
None